$5,500–8,000/mo in enrichment stack
and analyst headcount. Replaced at $399/mo.
Sift consolidates Clay's enrichment automation, Clearbit's data API, and your data analyst's 20-minutes-per-lead research workflow into one continuous intelligence layer — running before any sequence is ever written.
Cost equivalence: Clay ($400/mo) + Clearbit ($15K/yr ÷ 12 = $1,250/mo) + data analyst headcount ($4,000–6,000/mo) = $5,650–7,650/mo minimum.
From Scout lead to
fully enriched intelligence card.
Sift ingests every account and lead Scout surfaces — ICP-matched, signal-ranked, and ready for deep enrichment. No cold lists. No CSVs. Only pre-qualified prospects enter the pipeline.
Sift cross-references 50+ data sources simultaneously: Reoon for phone verification, Firecrawl for live company news, LinkedIn for activity signals and connection depth, Apollo for firmographics. Each field is confidence-scored.
M02B applies zero-tolerance classification: every lead is mapped to a department family and buying role. If a persona can't be determined with confidence, the lead is flagged — never forwarded with unknown context.
Each lead exits Sift as a verified intelligence card: phone, persona, LinkedIn signals, recent company news, and an enrichment confidence score (0–100). Scribe receives context, not a name.
Scroll to trigger the enrichment reveal. Each field populates in sequence as Sift completes its 50+ source cross-reference — ending with the enrichment confidence score that gates handoff to Scribe.
Four ways Sift
closes the intelligence gap.
“Scribe writes with assumptions. The personalization is surface-level. Your opener is generic because the context wasn't there. The SDR still spends 20 minutes per lead doing research that could have been done before the lead was ever assigned. Your sequences sound like templates — because they're built on template-level data.”
“Scribe opens with the Series B they just closed, references the two AE hires Signal caught, and addresses the VP Revenue persona directly. Replies come in because the lead felt seen — not sold. The research was done before the sequence was even assigned.”